PMID: 8594244Feb 28, 1996Paper

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

JAMA : the Journal of the American Medical Association
A H Soll

Abstract

To integrate the realization that peptic ulcer most commonly reflects infection with Helicobacter pylori or use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) into a disease management approach. Guidelines were outlined by the author and presented for review to the American College of Gastroenterology (ACG) Practice Parameters Committee, selected by the president of the ACG, and a panel of experts in peptic ulcer, selected by the committee. These guidelines were formulated following extensive review of the literature obtained by MEDLINE search and presented for detailed review and revision to unpublicized committee meetings on three occasions and to experts by mail. These recommendations are an official statement of the ACG and have been approved by the American Gastroenterological Association and the American Society for Gastroenterological Endoscopy. Firm recommendations are discriminated from reasonable suppositions pending definitive data. Since cure of H. pylori infection decreases recurrence rates and facilitates healing, antibiotic therapy is indicated for all H. pylori-infected ulcer patients. No optimal, simple antibiotic regimen has yet emerged. Simultaneous conventional ulcer therapy is recommende...Continue Reading

Citations

Sep 18, 2001·Clinical Therapeutics·M Robinson
Jan 5, 2000·BMJ : British Medical Journal·W A de Boer, G N Tytgat
Jun 1, 2013·BMC Complementary and Alternative Medicine·Jian-Hui XieZi-Ren Su
Sep 4, 1999·Journal of Clinical Pharmacy and Therapeutics·S P Vyas, V Sihorkar
Jan 18, 2006·Digestive Diseases and Sciences·Raffaella ScagliariniPaolo Pazzi
Jun 3, 2011·Digestive Diseases and Sciences·Vassilios KoussoulasMark Pimentel
Dec 24, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F LuzzaF Pallone
Apr 4, 2002·Alimentary Pharmacology & Therapeutics·T FurutaH Hanai
Jul 15, 1998·Alimentary Pharmacology & Therapeutics·G C SpinziG Minoli
Dec 21, 2000·Alimentary Pharmacology & Therapeutics·S Veldhuyzen Van ZantenP Sinclair
Feb 1, 1997·Alimentary Pharmacology & Therapeutics·W A de BoerG N Tytgat
Aug 1, 1997·Alimentary Pharmacology & Therapeutics·V SavarinoG Celle
Aug 1, 1997·Alimentary Pharmacology & Therapeutics·G TreiberU Klotz
Jun 1, 1997·Alimentary Pharmacology & Therapeutics·A M SeguraD Y Graham
Jun 25, 2005·European Journal of Clinical Pharmacology·Barbara Gawrońska-SzklarzMarek Droździk
Jun 20, 2006·European Journal of Clinical Pharmacology·Mikiko ShimizuTomonori Tateishi
Mar 24, 1998·Annual Review of Medicine·L Agréus, N J Talley
Oct 13, 2000·Gastroenterology Clinics of North America·T G Blanchard, S J Czinn
May 28, 2002·Journal of the American Pharmaceutical Association : APhA·Larry A DentGayle A Cochran
Dec 31, 1997·Ophthalmology·J S Mindel, E W Rosenberg
Mar 4, 2005·Environmental and Molecular Mutagenesis·Luis A HerreraPatricia Ostrosky-Wegman
May 19, 2009·Gastroenterology Clinics of North America·Lena Napolitano
Sep 20, 2005·Alimentary Pharmacology & Therapeutics·H PohlD J Robertson
Feb 5, 2005·Helicobacter·Dritana MarkoUNKNOWN GRESCA (Group for Eradication Studies from Catalonia and Aragón)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.